Literature DB >> 10766422

Differentiation status modulates transcription factor NF-kappaB activity in unstimulated human hepatocellular carcinoma cell lines.

T Z Liu1, C C Hu, Y H Chen, A Stern, J T Cheng.   

Abstract

We report herein a novel finding that under an unstimulated condition, a group of four human hepatocellular carcinoma (HCC) cell lines with varying degrees of differentiation, can spontaneously activate NF-KB. The propensity of activation coincided inversely with the differentiation status, with order being SK-Hep-1 > J5 > Hep3B > HepG2. Further studies indicate that this pattern of activation correlates excellently with the descending order of intracellular GSH/GSSG ratios as well as with the ascending order in the ability of these cells to generate hydrogen peroxide. Taken together, our data suggest that differentiation status may play a pivotal role in modulating intracellular thiol redox status and the extent of catalase expression, which may be crucial in the control of NF-kappaB activity in these HCC cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766422     DOI: 10.1016/s0304-3835(99)00404-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.

Authors:  Sanjay Batra; Ravi P Sahu; Prabodh K Kandala; Sanjay K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-05-18       Impact factor: 6.261

2.  The inhibitor of Ca(2+)-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB.

Authors:  Christian Freise; Martin Ruehl; Daniel Seehofer; Joachim Hoyer; Rajan Somasundaram
Journal:  Invest New Drugs       Date:  2012-10-02       Impact factor: 3.850

3.  (+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.

Authors:  Christian Freise; Wolfram Trowitzsch-Kienast; Martin Ruehl; Ulrike Erben; Daniel Seehofer; Ki Young Kim; Martin Zeitz; Rajan Somasundaram
Journal:  Invest New Drugs       Date:  2011-11-03       Impact factor: 3.850

4.  Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy.

Authors:  Andong Shao; Qin Xu; Walker T Spalek; Christopher F Cain; Chang Won Kang; Chih-Hang Anthony Tang; Juan R Del Valle; Chih-Chi Andrew Hu
Journal:  Mol Cancer Ther       Date:  2020-10-13       Impact factor: 6.261

5.  Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.

Authors:  Kristen K Ciombor; Yang Feng; Al Bowen Benson; Yingjun Su; Linda Horton; Sarah P Short; John Sae Wook Kauh; Charles Staley; Mary Mulcahy; Mark Powell; Katayoun I Amiri; Ann Richmond; Jordan Berlin
Journal:  Invest New Drugs       Date:  2014-06-04       Impact factor: 3.850

6.  A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines.

Authors:  Christian Freise; Martin Ruehl; Ulrike Erben; Ulf Neumann; Daniel Seehofer; Ki Young Kim; Wolfram Trowitzsch-Kienast; Thorsten Stroh; Martin Zeitz; Rajan Somasundaram
Journal:  BMC Complement Altern Med       Date:  2011-05-12       Impact factor: 3.659

7.  Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.

Authors:  Ruo-Chiau Wang; Chien-Yu Huang; Tai-Long Pan; Wei-Yu Chen; Chun-Te Ho; Tsan-Zon Liu; Yu-Jia Chang
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 8.  TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.

Authors:  Mariano Francesco Caratozzolo; Flaviana Marzano; Francesca Mastropasqua; Elisabetta Sbisà; Apollonia Tullo
Journal:  Genes (Basel)       Date:  2017-11-28       Impact factor: 4.096

9.  Curcumin improves expression of SCF/c-kit through attenuating oxidative stress and NF-κB activation in gastric tissues of diabetic gastroparesis rats.

Authors:  Qi-Hui Jin; Hong-Xia Shen; Hui Wang; Qi-Yang Shou; Qiang Liu
Journal:  Diabetol Metab Syndr       Date:  2013-03-01       Impact factor: 3.320

10.  Urinary Trypsin Inhibitor Ameliorates Seawater Immersion-Induced Intestinal Mucosa Injury via Antioxidation, Modulation of NF-κB Activity, and Its Related Cytokines in Rats with Open Abdominal Injury.

Authors:  Xing Jian Zhang; Ya Li Wang; Song Zhou; Xiaojun Xue; Qiang Liu; Wen Hua Zhang; Jun Zheng
Journal:  Gastroenterol Res Pract       Date:  2014-08-21       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.